Literature DB >> 23815575

Differential regulatory T cell activity in HIV type 1-exposed seronegative individuals.

Laura Pattacini1, Pamela M Murnane, Erin M Kahle, Michael J Bolton, Jeffrey J Delrow, Jairam R Lingappa, Elly Katabira, Deborah Donnell, M Juliana McElrath, Jared M Baeten, Jennifer M Lund.   

Abstract

The potential role of conventional and regulatory T cells (Tregs) in protection from HIV-1 infection remains unclear. To address this question, we analyzed samples from 129 HIV-1-exposed seronegative individuals (HESN) from an HIV-1-serodiscordant couples cohort. To assess the presence of HIV-specific T cell responses and Treg function, we measured the proliferation of T cells in response to HIV-1 peptide pools in peripheral blood mononuclear cells (PBMCs) and PBMCs depleted of Tregs. We identified HIV-specific CD4(+) and CD8(+) T cell responses and, surprisingly, the overall CD4(+) and CD8(+) T cell response rate was not increased when Tregs were removed from cell preparations. Of the 20 individuals that had HIV-1-specific CD4(+) T cell responses, only eight had Tregs that could suppress this proliferation. When compared with individuals whose Tregs could suppress HIV-1-specific CD4(+) T cell proliferation, individuals with Tregs unable to suppress showed a trend toward increased T cell activation and Treg frequency and a significant increase in HIV-1-specific production of microphage inflammatory protein-1β (MIP-1β) by CD4(+) T cells, autocrine production of which has been shown to be protective in terms of HIV-1 infection of CD4(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23815575      PMCID: PMC3785803          DOI: 10.1089/AID.2013.0075

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  51 in total

1.  Characterization of CD8 T-cell responses in HIV-1-exposed seronegative commercial sex workers from Nairobi, Kenya.

Authors:  Judie B Alimonti; Joshua Kimani; Lucy Matu; Charles Wachihi; Rupert Kaul; Francis A Plummer; Keith R Fowke
Journal:  Immunol Cell Biol       Date:  2006-10       Impact factor: 5.126

2.  CD4+ T cell responses in HIV-exposed seronegative women are qualitatively distinct from those in HIV-infected women.

Authors:  Judie B Alimonti; Sandra A Koesters; Joshua Kimani; Lucy Matu; Charles Wachihi; Francis A Plummer; Keith R Fowke
Journal:  J Infect Dis       Date:  2004-12-01       Impact factor: 5.226

3.  Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation.

Authors:  Fusheng Li; Uma Malhotra; Peter B Gilbert; Natalie R Hawkins; Ann C Duerr; Juliana M McElrath; Lawrence Corey; Steven G Self
Journal:  Vaccine       Date:  2006-06-27       Impact factor: 3.641

4.  Frequencies of ex vivo-activated human immunodeficiency virus type 1-specific gamma-interferon-producing CD8+ T cells in infected children correlate positively with plasma viral load.

Authors:  Florence Buseyne; Daniel Scott-Algara; Françoise Porrot; Béatrice Corre; Nassima Bellal; Marianne Burgard; Christine Rouzioux; Stéphane Blanche; Yves Rivière
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients.

Authors:  Monica Schenal; Sergio Lo Caputo; Francesca Fasano; Francesca Vichi; Marina Saresella; Piera Pierotti; Maria Luisa Villa; Francesco Mazzotta; Daria Trabattoni; Mario Clerici
Journal:  AIDS       Date:  2005-04-29       Impact factor: 4.177

6.  Spontaneous and antigen-induced chemokine production in exposed but uninfected partners of HIV type 1-infected individuals in North India.

Authors:  P Suresh; Ajay Wanchu; Archana Bhatnagar; Ravinder Kaur Sachdeva; Meera Sharma
Journal:  AIDS Res Hum Retroviruses       Date:  2007-02       Impact factor: 2.205

7.  Human immunodeficiency virus (HIV) gag antigen-specific T-helper and granule-dependent CD8 T-cell activities in exposed but uninfected heterosexual partners of HIV type 1-infected individuals in North India.

Authors:  Suresh Pallikkuth; Ajay Wanchu; Archana Bhatnagar; Ravinder Kaur Sachdeva; Meera Sharma
Journal:  Clin Vaccine Immunol       Date:  2007-09

8.  Systemic immune activation in HIV-1-exposed uninfected Vietnamese intravascular drug users.

Authors:  Hung K Tran; Loïc Chartier; Lien X Troung; Ngai N Nguyen; Arnaud Fontanet; François E Barré-Sinoussi; Gianfranco Pancino; Daniel Scott-Algara
Journal:  AIDS Res Hum Retroviruses       Date:  2006-03       Impact factor: 2.205

9.  A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses.

Authors:  Koen Venken; Marielle Thewissen; Niels Hellings; Veerle Somers; Karen Hensen; Jean-Luc Rummens; Piet Stinissen
Journal:  J Immunol Methods       Date:  2007-03-05       Impact factor: 2.303

10.  Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal.

Authors:  Fatema A Legrand; Douglas F Nixon; Christopher P Loo; Erika Ono; Joan M Chapman; Maristela Miyamoto; Ricardo S Diaz; Amélia M N Santos; Regina C M Succi; Jacob Abadi; Michael G Rosenberg; Maria Isabel de Moraes-Pinto; Esper G Kallas
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

View more
  10 in total

1.  Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 Infection.

Authors:  Laura Pattacini; Jared M Baeten; Katherine K Thomas; Tayler R Fluharty; Pamela M Murnane; Deborah Donnell; Elizabeth Bukusi; Allan Ronald; Nelly Mugo; Jairam R Lingappa; Connie Celum; M Juliana McElrath; Jennifer M Lund
Journal:  J Acquir Immune Defic Syndr       Date:  2016-06-01       Impact factor: 3.731

2.  Discordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV.

Authors:  Afsar Rahbar; Inti Peredo; Nina Wolmer Solberg; Chato Taher; Mensur Dzabic; Xinling Xu; Petra Skarman; Olesja Fornara; Charlotte Tammik; Koon Yaiw; Vanessa Wilhelmi; Alice Assinger; Giuseppe Stragliotto; Cecilia Söderberg-Naucler
Journal:  Oncoimmunology       Date:  2015-02-25       Impact factor: 8.110

3.  Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons.

Authors:  Laura Pattacini; Pamela M Murnane; Jared M Baeten; Tayler R Fluharty; Katherine K Thomas; Elizabeth Bukusi; Elly Katabira; Nelly Mugo; Deborah Donnell; Jairam R Lingappa; Connie Celum; Mark Marzinke; M Juliana McElrath; Jennifer M Lund
Journal:  J Infect Dis       Date:  2014-12-17       Impact factor: 5.226

Review 4.  The Immune Fulcrum: Regulatory T Cells Tip the Balance Between Pro- and Anti-inflammatory Outcomes upon Infection.

Authors:  Laura E Richert-Spuhler; Jennifer M Lund
Journal:  Prog Mol Biol Transl Sci       Date:  2015-08-18       Impact factor: 3.622

5.  Association between cellular immune activation, target cell frequency, and risk of human immunodeficiency virus type 1 superinfection.

Authors:  Catherine A Blish; Ozge C Dogan; Walter Jaoko; R Scott McClelland; Kishorchandra Mandaliya; Katherine Odem-Davis; Barbra A Richardson; Julie Overbaugh
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

Review 6.  Immune quiescence: a model of protection against HIV infection.

Authors:  Catherine M Card; Terry Blake Ball; Keith R Fowke
Journal:  Retrovirology       Date:  2013-11-20       Impact factor: 4.602

7.  CD101 genetic variants modify regulatory and conventional T cell phenotypes and functions.

Authors:  Laura E Richert-Spuhler; Corinne M Mar; Paurvi Shinde; Feinan Wu; Ting Hong; Evan Greene; Sharon Hou; Katherine Thomas; Raphael Gottardo; Nelly Mugo; Guy de Bruyn; Connie Celum; Jared M Baeten; Jairam R Lingappa; Jennifer M Lund
Journal:  Cell Rep Med       Date:  2021-06-15

8.  Transient Increases in Inflammation and Proapoptotic Potential Are Associated with the HESN Phenotype Observed in a Subgroup of Kenyan Female Sex Workers.

Authors:  Marcel Gluchowski; Xiaoqiong Yu; Bernard Abrenica; Samantha Yao; Joshua Kimani; Renée N Douville; Terry Blake Ball; Ruey-Chyi Su
Journal:  Viruses       Date:  2022-02-25       Impact factor: 5.048

9.  Reducing IRF-1 to Levels Observed in HESN Subjects Limits HIV Replication, But Not the Extent of Host Immune Activation.

Authors:  Ruey-Chyi Su; Andrew Plesniarski; Zhujun Ao; Joshua Kimani; Aida Sivro; Walter Jaoko; Frank A Plummer; Xiaojian Yao; Terry Blake Ball
Journal:  Mol Ther Nucleic Acids       Date:  2015-10-27       Impact factor: 10.183

10.  HIV-Exposed Seronegative Sex Workers Express Low T-Cell Activation and an Intact Ectocervical Tissue Microenvironment.

Authors:  Maria Röhl; Annelie Tjernlund; Julie Lajoie; Gabriella Edfeldt; Frideborg Bradley; Sofia Bergström; Vilde Kaldhusdal; Alexandra Åhlberg; Anna Månberg; Kenneth Omollo; Geneviève Boily-Larouche; Muhammad Asghar; Douglas S Kwon; Julius Oyugi; Joshua Kimani; Peter Nilsson; Keith R Fowke; Kristina Broliden
Journal:  Vaccines (Basel)       Date:  2021-03-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.